Astal Laboratories [ASTALLTD] vs Vishal Mega Mart [VMM] Detailed Stock Comparison

Astal Laboratories
BSE
Loading...

Vishal Mega Mart
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Astal Laboratories wins in 12 metrics, Vishal Mega Mart wins in 5 metrics, with 0 ties. Astal Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Astal Laboratories | Vishal Mega Mart | Better |
---|---|---|---|
P/E Ratio (TTM) | 11.37 | 102.21 | Astal Laboratories |
Price-to-Book Ratio | 2.49 | 10.00 | Astal Laboratories |
Debt-to-Equity Ratio | 36.86 | 27.02 | Vishal Mega Mart |
PEG Ratio | N/A | 2.79 | N/A |
EV/EBITDA | 7.83 | 42.40 | Astal Laboratories |
Profit Margin (TTM) | 14.02% | 5.90% | Astal Laboratories |
Operating Margin (TTM) | 16.56% | 7.32% | Astal Laboratories |
EBITDA Margin (TTM) | 16.56% | 7.32% | Astal Laboratories |
Return on Equity | 30.09% | 10.51% | Astal Laboratories |
Return on Assets (TTM) | 17.86% | 6.35% | Astal Laboratories |
Free Cash Flow (TTM) | $-203.57M | $11.35B | Vishal Mega Mart |
1-Year Return | 1.78% | 37.38% | Vishal Mega Mart |
Price-to-Sales Ratio (TTM) | 1.41 | 6.29 | Astal Laboratories |
Enterprise Value | $1.01B | $648.85B | Vishal Mega Mart |
EV/Revenue Ratio | 1.59 | 6.06 | Astal Laboratories |
Gross Profit Margin (TTM) | 21.79% | 28.26% | Vishal Mega Mart |
Revenue per Share (TTM) | $65 | $24 | Astal Laboratories |
Earnings per Share (Diluted) | $8.04 | $1.36 | Astal Laboratories |
Beta (Stock Volatility) | -0.81 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Astal Laboratories vs Vishal Mega Mart Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Astal Laboratories | 1.92% | 8.74% | 13.24% | 15.51% | 7.21% | 21.02% |
Vishal Mega Mart | -3.83% | -1.46% | 7.09% | 16.63% | 24.87% | 31.25% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Astal Laboratories | 1.78% | 107.26% | 107.26% | 107.26% | 107.26% | 107.26% |
Vishal Mega Mart | 37.38% | 37.38% | 37.38% | 37.38% | 37.38% | 37.38% |
Performance & Financial Health Analysis: Astal Laboratories vs Vishal Mega Mart
Metric | ASTALLTD | VMM |
---|---|---|
Market Information | ||
Market Cap | ₹898.37M | ₹673.80B |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 24,421 | 18,087,622 |
90 Day Avg. Volume | 31,810 | 17,260,805 |
Last Close | ₹95.18 | ₹139.01 |
52 Week Range | ₹66.72 - ₹131.70 | ₹95.99 - ₹149.17 |
% from 52W High | -27.73% | -6.81% |
All-Time High | ₹131.70 (Sep 09, 2024) | ₹149.17 (Aug 06, 2025) |
% from All-Time High | -27.73% | -6.81% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.90% | 0.23% |
Quarterly Earnings Growth | 9.67% | 0.88% |
Financial Health | ||
Profit Margin (TTM) | 0.14% | 0.06% |
Operating Margin (TTM) | 0.17% | 0.07% |
Return on Equity (TTM) | 0.30% | 0.11% |
Debt to Equity (MRQ) | 36.86 | 27.02 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹36.75 | ₹13.90 |
Cash per Share (MRQ) | ₹1.77 | ₹1.85 |
Operating Cash Flow (TTM) | ₹-125,173,000 | ₹13.99B |
Levered Free Cash Flow (TTM) | ₹89.25M | ₹9.36B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Astal Laboratories vs Vishal Mega Mart
Metric | ASTALLTD | VMM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 11.37 | 102.21 |
Forward P/E | N/A | 66.16 |
PEG Ratio | N/A | 2.79 |
Price to Sales (TTM) | 1.41 | 6.29 |
Price to Book (MRQ) | 2.49 | 10.00 |
Market Capitalization | ||
Market Capitalization | ₹898.37M | ₹673.80B |
Enterprise Value | ₹1.01B | ₹648.85B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.59 | 6.06 |
Enterprise to EBITDA | 7.83 | 42.40 |
Risk & Other Metrics | ||
Beta | -0.81 | N/A |
Book Value per Share (MRQ) | ₹36.75 | ₹13.90 |
Financial Statements Comparison: Astal Laboratories vs Vishal Mega Mart
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ASTALLTD | VMM |
---|---|---|
Revenue/Sales | ₹234.67M | ₹25.48B |
Cost of Goods Sold | ₹183.53M | ₹18.28B |
Gross Profit | ₹51.14M | ₹7.20B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹40.79M | ₹1.86B |
EBITDA | ₹42.18M | ₹3.76B |
Pre-Tax Income | ₹38.49M | ₹1.56B |
Income Tax | ₹11.04M | ₹406.24M |
Net Income (Profit) | ₹27.45M | ₹1.15B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ASTALLTD | VMM |
---|---|---|
Cash & Equivalents | ₹17.30M | ₹3.97B |
Total Current Assets | ₹456.39M | ₹31.02B |
Total Current Liabilities | ₹267.71M | ₹23.33B |
Long-Term Debt | ₹4.56M | ₹12.22B |
Total Shareholders Equity | ₹359.95M | ₹64.01B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | N/A | ₹22.41B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ASTALLTD | VMM |
---|---|---|
Operating Cash Flow | N/A | ₹-2.69B |
Capital Expenditures | N/A | ₹-587.39M |
Free Cash Flow | N/A | ₹1.08B |
Debt Repayment | N/A | ₹0 |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ASTALLTD | VMM |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 24,421 | 18,087,622 |
Average Daily Volume (90 Day) | 31,810 | 17,260,805 |
Shares Outstanding | 9.83M | 4.60B |
Float Shares | 3.37M | 1.98B |
% Held by Insiders | 0.57% | 0.55% |
% Held by Institutions | 0.00% | 0.31% |
Dividend Analysis & Yield Comparison: Astal Laboratories vs Vishal Mega Mart
Metric | ASTALLTD | VMM |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |